Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B7725 MethylmalonateSummary: reversible succinate dehydrogenase inhibitor
-
B5697 WIN 18446Summary: inhibitor of aldehyde dehydrogenase 1a2 (ALDH1a2)
-
B5716 GalloflavinSummary: human lactate dehydrogenase (LDH) inhibitor
-
C5603 A-771726Summary: dihydroorotate dehydrogenase inhibitor
-
C5478 NCT-502Summary: inhibitor of 3-phosphoglycerate dehydrogenase (PHGDH)